Skip to main content
. 2011 Jan-Jun;6(1):26–31. doi: 10.4103/1793-5482.85632

Figure 2.

Figure 2

Effect of magnesium sulfate vs. control on risk of poor outcome 3-6 months after aneurismal subarachnoid hemorrhage. There is a decreased risk of poor outcome with magnesium treatment. Poor outcome is defined as death, vegetative state, or sever disability, as measured by Glasgow outcome scale, extended Glasgow outcome scale, and modified Rankin scale score